AAAAAA
Results: 1-25/28
Authors:
Kerbel, RS
Citation: Rs. Kerbel, Clinical trials of antiangiogenic drugs: Opportunities, problems, and assessment of initial results, J CL ONCOL, 19(18), 2001, pp. 45S-51S
Authors:
Master, Z
Jones, N
Tran, J
Jones, J
Kerbel, RS
Dumont, DJ
Citation: Z. Master et al., Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak, EMBO J, 20(21), 2001, pp. 5919-5928
Authors:
Rak, J
Kerbel, RS
Citation: J. Rak et Rs. Kerbel, Ras regulation of vascular endothelial growth factor and angiogenesis, METH ENZYM, 333, 2001, pp. 267-283
Authors:
Mayer, B
Klement, G
Kaneko, M
Man, S
Jothy, S
Rak, J
Kerbel, RS
Citation: B. Mayer et al., Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas, GASTROENTY, 121(4), 2001, pp. 839-852
Authors:
Viloria-Petit, A
Crombet, T
Jothy, S
Hicklin, D
Bohlen, P
Schlaeppi, JM
Rak, J
Kerbel, RS
Citation: A. Viloria-petit et al., Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: A role for altered tumor angiogenesis, CANCER RES, 61(13), 2001, pp. 5090-5101
Authors:
Frankel, A
Rosen, K
Filmus, J
Kerbel, RS
Citation: A. Frankel et al., Induction of anoikis and suppression of human ovarian tumor growth in vivoby down-regulation of Bcl-X-L, CANCER RES, 61(12), 2001, pp. 4837-4841
Authors:
Yu, JL
Rak, JW
Carmeliet, P
Nagy, A
Kerbel, RS
Coomber, BL
Citation: Jl. Yu et al., Heterogeneous vascular dependence of tumor cell populations, AM J PATH, 158(4), 2001, pp. 1325-1334
Authors:
Rak, J
Yu, JL
Klement, G
Kerbel, RS
Citation: J. Rak et al., Oncogenes and angiogenesis: Signaling three-dimensional tumor growth, J INV D SYM, 5(1), 2000, pp. 24-33
Authors:
Frankel, A
Man, S
Elliott, P
Adams, J
Kerbel, RS
Citation: A. Frankel et al., Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341, CLIN CANC R, 6(9), 2000, pp. 3719-3728
Authors:
Pak, BJ
Li, Q
Kerbel, RS
Ben-David, Y
Citation: Bj. Pak et al., TYRP2-mediated resistance to cis-diamminedichloroplatinum (II) in human melanoma cells is independent of tyrosinase and TYRP1 expression and melanin content, MELANOMA RE, 10(5), 2000, pp. 499-505
Authors:
Kerbel, RS
Viloria-Petit, A
Klement, G
Rak, J
Citation: Rs. Kerbel et al., 'Accidental' anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples, EUR J CANC, 36(10), 2000, pp. 1248-1257
Authors:
Lopez-Ocejo, O
Viloria-Petit, A
Bequet-Romero, M
Mukhopadhyay, D
Rak, J
Kerbel, RS
Citation: O. Lopez-ocejo et al., Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner, ONCOGENE, 19(40), 2000, pp. 4611-4620
Authors:
Chu, W
Pak, BJ
Bani, MR
Kapoor, M
Lu, SJ
Tamir, A
Kerbel, RS
Ben-David, Y
Citation: W. Chu et al., Tyrosinase-related protein 2 as a mediator of melanoma specific resistanceto cis-diamminedichloroplatinum(II): therapeutic implications, ONCOGENE, 19(3), 2000, pp. 395-402
Authors:
Goertz, DE
Christopher, DA
Yu, JL
Kerbel, RS
Burns, PN
Foster, FS
Citation: De. Goertz et al., High-frequency color flow imaging of the microcirculation, ULTRASOUN M, 26(1), 2000, pp. 63-71
Authors:
Kerbel, RS
Citation: Rs. Kerbel, Tumor angiogenesis: past, present and the near future, CARCINOGENE, 21(3), 2000, pp. 505-515
Authors:
Klement, G
Baruchel, S
Rak, J
Man, S
Clark, K
Hicklin, DJ
Bohlen, P
Kerbel, RS
Citation: G. Klement et al., Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity, J CLIN INV, 105(8), 2000, pp. R15-R24
Authors:
Rosen, K
Rak, J
Leung, T
Dean, NM
Kerbel, RS
Filmus, J
Citation: K. Rosen et al., Activated ras prevents downregulation of Bcl-X-L triggered by detachment from the extracellular matrix: A mechanism of ras-induced resistance to anoikis in intestinal epithelial cells, J CELL BIOL, 149(2), 2000, pp. 447-455
Authors:
Rak, J
Mitsuhashi, Y
Sheehan, C
Tamir, A
Viloria-Petit, A
Filmus, J
Mansour, SJ
Ahn, NG
Kerbel, RS
Citation: J. Rak et al., Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts, CANCER RES, 60(2), 2000, pp. 490-498
Authors:
Florenes, VA
Lu, C
Bhattacharya, N
Rak, J
Sheehan, C
Slingerland, JM
Kerbel, RS
Citation: Va. Florenes et al., Interleukin-6 dependent induction of the cyclin dependent kinase inhibitorp21(WAF1/CIP1) is lost during progression of human malignant melanoma, ONCOGENE, 18(4), 1999, pp. 1023-1032
Authors:
Green, SK
Frankel, A
Kerbel, RS
Citation: Sk. Green et al., Adhesion-dependent multicellular drug resistance, ANTI-CAN DR, 14(2), 1999, pp. 153-168
Authors:
Kerbel, RS
Citation: Rs. Kerbel, Monoclonal antibodies in cancer therapy: An overview, CANC METAST, 18(4), 1999, pp. 409-410
Authors:
Feldkamp, MM
Lau, N
Rak, J
Kerbel, RS
Guha, A
Citation: Mm. Feldkamp et al., Normoxic and hypoxic regulation of vascular endothelial growth Factor (VEGF) by astrocytoma cells is mediated by Ras, INT J CANC, 81(1), 1999, pp. 118-124
Authors:
MacDougall, JR
Bani, MR
Lin, Y
Muschel, RJ
Kerbel, RS
Citation: Jr. Macdougall et al., 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression, BR J CANC, 80(3-4), 1999, pp. 504-512
Authors:
Tran, J
Rak, J
Sheehan, C
Saibil, SD
LaCasse, E
Korneluk, RG
Kerbel, RS
Citation: J. Tran et al., Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells, BIOC BIOP R, 264(3), 1999, pp. 781-788
Authors:
Krestow, JK
Rak, J
Filmus, J
Kerbel, RS
Citation: Jk. Krestow et al., Functional dissociation of anoikis-like cell death and activity of Stress Activated Protein Kinase, BIOC BIOP R, 260(1), 1999, pp. 48-53